Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participants
Zonglin Li(Peking University), Linong Ji(Peking University), Suiyuan Hu(Peking University), Wenjia Yang(Peking University), Lin Chu, Jinyu Zhou(Peking University), Fang Lv(Liaoning Normal University), Xingyun Zhu(Peking University), Xiaoling Cai(Peking University)
Cited by 0
Related Papers
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115